DIAMOND Trial: Patiromer for the Management of Hyperkalemia in Subjects Receiving RAASi Medications for Heart Failure with Reduced Ejection Fraction

23 May 2022 (16:14 - 16:26)
Organised by:
Congress Presentation Part of: Late-Breaking Trials - Pharmacological treatment II Heart Failure with Reduced Ejection Fraction (HFrEF) HFA Premium Access Heart Failure 2022

ESC 365 is supported by

ESC 365 is supported by